The quarter showed solid organic growth, but $303k in one-time settlement income inflated earnings. Monitor next quarter for normalization of ASI purchases and Renacidin demand to assess recurring revenue trajectory.
Price Chart
Executive Summary
United-Guardian reported Q1 2026 revenue of $2.87M (+16% YoY) and EPS of $0.18 (+50% YoY), driven by 24% growth in pharmaceutical sales and 21% growth in cosmetic ingredients. Results include $303k in settlement income; operating income rose only 5% excluding the settlement.
Key Financial Metrics
Key Facts
- Revenue $2,872,222 vs $2,481,127 YoY (+15.8%)
- Net income $818,902 vs $560,895 YoY (+46.0%)
- EPS $0.18 vs $0.12 YoY (+50.0%)
- Pharmaceutical sales +24%, cosmetic ingredients +21%
- Settlement income of $303,133 from contract manufacturer shutdown
- Operating income increased 5.2% to $642,449 (excluding settlement)
- No forward guidance provided
Financial Impact
Revenue beat was not quantified due to lack of consensus; EPS grew 50% YoY but included one-time settlement income.
Risk Factors
- Settlement income is non-recurring; operating income growth was modest (~5%)
- Heavy reliance on Renacidin (pharmaceutical product) and ASI (distributor)
- No quantitative forward guidance; management optimism is subjective
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291077 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 7, 2026 11w ago | Press Release | $7.29 | awaiting T+60 | — | $6.67 (−8.50%) |
Jul 16, 2026 14w ago | 8-K | $7.50 $7.00 | ▼ −6.67% | ▼ −10.38% | $6.67 (−11.07%) |
May 8, 2026 24w ago | 8-K | $6.87 $7.10 | ▲ +3.35% | ▼ −1.49% | $6.67 (−2.91%) |
May 8, 2026 24w ago | Press Release | $6.87 $7.10 | ▲ +3.35% | ▼ −1.49% | $6.67 (−2.91%) |
Mar 27, 2026 30w ago | Press Release | $6.56 $7.11 | ▼ −8.38% | ▲ +7.68% | $6.67 (−1.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers